Silexion Therapeutics Corp — Form 8-K
Filed August 13, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 18/100
What the filing says
Silexion Therapeutics Corp filed warrant forms for a securities offering dated August 11, 2026. The filing exhibits three warrant types: Series E Ordinary Warrants (exercise price $0.65, 5-year term), Pre-Funded Warrants (exercise price $0.0001, pre-funded), and Placement Agent Warrants (exercise price $0.8125, 5-year term to August 2031). Specific warrant share counts and dollar amounts are blank templates. The offering involves up to $2.5M in securities (Shares and Warrants) with H.C. Wainwright Co. as placement agent.
Why this rating
Boilerplate warrant forms with no concrete deal terms specified. Event is routine capital raise documentation for tiny ($4.6M asset) biotech firm; immaterial relative to company size.
See more from August 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.